Skip to content

DOCAM

Active
Private limited company·Activiteiten van medisch specialisten· 5 yrs active
Haringrodestraat 8 ·2018 Antwerpen, Belgium
KBO/BCE: BE 0764.954.074
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of DOCAM is 0.2% (very low). The 2024 annual accounts show equity of €486k and a net result of €482k. Equity is growing by ~43.4% per year across the filed fiscal years. Its solvency ranks better than 28% of 6584 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 20 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-07-2025, 1 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 30-07-2025 1 d early 2025-00331124
31-12-2023 31-07-2024 03-07-2024 28 d early 2024-00200633
31-12-2022 31-07-2023 24-07-2023 7 d early 2023-00262011
31-12-2021 31-07-2022 29-07-2022 2 d early 2022-20253904

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€482k+39.7%
Working capital€484k-41.0%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 30-07-2025 with the NBB · fiscal year 2024 · micro
€0€200k€400k€600kOperating result 2021: €212k€212kNet result 2021: €162k€162kOperating result 2022: €411k€411kNet result 2022: €311k€311kOperating result 2023: €456k€456kNet result 2023: €345k€345kOperating result 2024: €639k€639kNet result 2024: €482k€482k2021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~43.4%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€500k€1.00M€1.50M€2.00M2025: €1.05M (€837k - €1.27M)2026: €1.26M (€917k - €1.60M)2027: €1.47M (€997k - €1.94M)2021: €165k2022: €476k2023: €821k2024: €486k2021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 40.2% 66.7%
better than 28% of 6584 sector peers
Net result €482k €46k
better than 95% of 6578 sector peers
Equity €486k €79k
better than 95% of 6584 sector peers
Gross operating margin €639k €78k
better than 95% of 6586 sector peers
Total assets €1.21M €154k
better than 95% of 6587 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P28
2021: P94 · n=18482022: P95 · n=36852023: P95 · n=53472024: P28 · n=65842021 2024
Weakening position over 2021-2024 · n=1848-6584
Net result P95
2021: P92 · n=18482022: P95 · n=36832023: P95 · n=53462024: P95 · n=65782021 2024
Stable position over 2021-2024 · n=1848-6578
Equity P95
2021: P80 · n=18482022: P95 · n=36852023: P95 · n=53492024: P95 · n=65842021 2024
Stable position over 2021-2024 · n=1848-6584
Gross operating margin P95
2021: P88 · n=18492022: P95 · n=36812023: P95 · n=53432024: P95 · n=65862021 2024
Stable position over 2021-2024 · n=1849-6586
Describes the position versus peers, not a forecast.
EBITDA
€639k
+39.9% 21-24
Net profit
€482k
+39.7% 21-24
Cash flow
€482k
+39.7% 21-24
Total assets
€1.21M
+43.4% 21-24
Equity
€486k
-40.8% 21-24
Working capital
€484k
-41.0% 21-24
Income taxes
€155k
+41.7% 21-24
Dividends
€817k
- 21-24
Show 9 other metrics
Debt
€722k
+3216.9% 21-24
Debt ≤ 1y
€722k
+3216.9% 21-24
Current ratio
1.67
-95.7% 21-24
Quick ratio
1.67
-95.7% 21-24
Solvency
40.2%
-58.7% 21-24
Debt / equity
1.49
+5504.2% 21-24
ROE
99.3%
+136.1% 21-24
ROA
39.9%
-2.5% 21-24
Interest coverage
379.88
+83.3% 21-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€639k
Net profit€482k
Cash flow€482k
Staff costs-
Income taxes€155k
Dividends€817k
Total assets€1.21M
Equity€486k
Debt€722k
of which ≤ 1y€722k
of which > 1y-
Working capital€484k
Employees (FTE)-
Ratios (computed)
2024
Current ratio1.67
Quick ratio1.67
Working capital ratio40.1%
Solvency40.2%
Debt / equity1.49
Long-term debt ratio-
Interest coverage379.88
Gross margin-
Net margin-
ROA39.9%
ROE99.3%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (19 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€1.21M
Fixed assets 21/28€1k
Tangible fixed assets 22/27€1k
Current assets 29/58€1.21M
Cash & bank 54/58€1.20M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.21M
Equity 10/15€486k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€483k
Amounts payable 17/49€722k
Amounts payable within one year 42/48€722k
Trade debts payable within one year 44€93
Income statement
Gross operating margin 9900€639k
Operating result 9901€639k
Financial charges 65€2k
Result before taxes 9903€637k
Income taxes 67/77€155k
Net result for the period 9904€482k
Result to be appropriated 9905€482k
This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
91 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
DOCAM
Haringrodestraat 8, 2018 AntwerpenActiviteiten van medisch specialisten
since 20212.314.250.942
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area149 m²
Buildings1
Building footprint119 m²
Volume (LiDAR)1,247 m³
Tallest building14.8 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11806F1389/00Z006 Flanders 149 m² 1 · 119 m² 14.8 m · 5 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

0 of 1 acts read

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Financial profile

5 of 5 axes measured
Health91Profitability100Solvency77Growth78Stability94
88 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 91
Profitability 100
Solvency 77
Growth 78
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL DOCAM
Registered office
Haringrodestraat 8
2018 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.